Gabapentin monotherapy for newly diagnosed partial epilepsy

被引:0
|
作者
Anderson, WT
Sakhoury, T
Nasreddine, W
Abou-Khalil, B
Beydoun, A
机构
[1] Univ Michigan, Med Ctr, Ann Arbor, MI 48109 USA
[2] Vanderbilt Univ, Nashville, TN USA
关键词
D O I
暂无
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
引用
收藏
页码:224 / 224
页数:1
相关论文
共 50 条
  • [1] GABAPENTIN (NEURONTIN) AS MONOTHERAPY IN NEWLY-DIAGNOSED PATIENTS WITH PARTIAL EPILEPSY
    ANHUT, H
    GREINER, M
    MOCKEL, V
    MURRAY, G
    EPILEPSIA, 1995, 36 : S119 - S119
  • [2] Monotherapy trials with gabapentin for partial epilepsy
    Beydoun, A
    EPILEPSIA, 1999, 40 : S13 - S16
  • [3] A double-blind trial of gabapentin monotherapy for newly diagnosed partial seizures
    Chadwick, DW
    Anhut, H
    Greiner, MJ
    Alexander, J
    Murray, GH
    Garofalo, EA
    Pierce, MW
    NEUROLOGY, 1998, 51 (05) : 1282 - 1288
  • [4] Gabapentin versus lamotrigine monotherapy: A double-blind comparison in newly diagnosed epilepsy
    Brodie, MJ
    Chadwick, TW
    Anhut, H
    Otte, A
    Messmer, SL
    Maton, S
    Sauermann, W
    Murray, G
    Garofalo, EA
    EPILEPSIA, 2002, 43 (09) : 993 - 1000
  • [5] A comparison of monotherapy with lamotrigine or carbamazepine in patients with newly diagnosed partial epilepsy
    Nieto-Barrera, M
    Brozmanova, M
    Capovilla, G
    Christe, W
    Pedersen, B
    Kane, K
    O'Neill, F
    EPILEPSY RESEARCH, 2001, 46 (02) : 145 - 155
  • [6] Cognitive and Psychosocial Effects of Oxcarbazepine Monotherapy in Newly Diagnosed Partial Epilepsy
    Kim, Daeyoung
    Seo, Ji-Hye
    Joo, Eun Yeon
    Lee, Hyang Woon
    Shin, Won Chul
    Hong, Seung Bong
    CLINICAL NEUROPHARMACOLOGY, 2014, 37 (04) : 100 - 107
  • [7] Lacosamide monotherapy for newly diagnosed epilepsy
    Brigo, Francesco
    LANCET NEUROLOGY, 2017, 16 (01): : 20 - 22
  • [9] Topiramate - As monotherapy in newly diagnosed epilepsy
    Waugh, J
    Goa, KL
    CNS DRUGS, 2003, 17 (13) : 985 - 992
  • [10] TopiramateAs Monotherapy in Newly Diagnosed Epilepsy
    John Waugh
    Karen L. Goa
    CNS Drugs, 2003, 17 : 985 - 992